These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18264647)

  • 21. Long-acting inhaled beta(2)-agonist therapy in asthma.
    Kips JC; Pauwels RA
    Am J Respir Crit Care Med; 2001 Sep; 164(6):923-32. PubMed ID: 11587972
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma.
    Dempsey OJ; Fowler SJ; Wilson A; Kennedy G; Lipworth BJ
    Chest; 2002 Jul; 122(1):151-9. PubMed ID: 12114351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Guideline for the management of chronic asthma in children--2000 update. Allergy Society of South Africa Working Group.
    Motala C; Kling S; Gie R; Potter PC; Manjra A; Vermeulen J; Weinberg EG; Green R
    S Afr Med J; 2000 May; 90(5 Pt 2):524-8, 530, 532 passim. PubMed ID: 10901828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beclomethasone and albuterol in mild asthma.
    Merkus PJ
    N Engl J Med; 2007 Aug; 357(5):506; author reply 506-7. PubMed ID: 17671262
    [No Abstract]   [Full Text] [Related]  

  • 25. Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.
    Turner MO; Johnston PR; Pizzichini E; Pizzichini MM; Hussack PA; Hargreave FE
    Can Respir J; 1998; 5(4):261-8. PubMed ID: 9753527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of regular treatment with inhaled corticosteroid or leukotriene receptor antagonist in mild intermittent asthma.
    Tamaoki J; Isono K; Taira M; Tagaya E; Nakata J; Kawatani K; Nagai A
    Allergy Asthma Proc; 2008; 29(2):189-96. PubMed ID: 18430318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of theophylline or pranlukast, a cysteinyl leukotriene receptor 1 antagonist, as add-on therapy in uncontrolled asthmatic patients with a medium dose of inhaled corticosteroids.
    Tsuchida T; Matsuse H; Machida I; Kondo Y; Saeki S; Tomari S; Obase Y; Matsuo N; Shimoda T; Kohno S
    Allergy Asthma Proc; 2005; 26(4):287-91. PubMed ID: 16270722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Additive bronchoprotective and bronchodilator effects with single doses of salmeterol and montelukast in asthmatic patients receiving inhaled corticosteroids.
    Dempsey OJ; Wilson AM; Sims EJ; Mistry C; Lipworth BJ
    Chest; 2000 Apr; 117(4):950-3. PubMed ID: 10767223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
    Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS
    Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in adults and children aged 12 years and over.
    Shepherd J; Rogers G; Anderson R; Main C; Thompson-Coon J; Hartwell D; Liu Z; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(19):iii-iv, 1-360. PubMed ID: 18485271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New combination therapies for asthma.
    Donohue JF; Ohar JA
    Curr Opin Pulm Med; 2001 Mar; 7(2):62-8. PubMed ID: 11224725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination Inhaled Corticosteroid/Long Acting Beta Agonist Therapy- An Evolving Role in Asthma Care.
    Walsh J; Murphy DM
    Ir Med J; 2019 Feb; 112(2):864. PubMed ID: 30839181
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-term efficacy and safety of fluticasone propionate powder administered once or twice daily via inhaler to patients with moderate asthma.
    ZuWallack R; Adelglass J; Clifford DP; Duke SP; Wire PD; Faris M; Harding SM
    Chest; 2000 Aug; 118(2):303-12. PubMed ID: 10936117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. As-needed inhaled beta2-adrenoceptor agonists in moderate-to-severe asthma: current recommendations.
    Cockcroft DW
    Treat Respir Med; 2005; 4(3):169-74. PubMed ID: 15987233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term asthma control with oral montelukast and inhaled beclomethasone for adults and children 6 years and older.
    Williams B; Noonan G; Reiss TF; Knorr B; Guerra J; White R; Matz J
    Clin Exp Allergy; 2001 Jun; 31(6):845-54. PubMed ID: 11422148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beclomethasone and albuterol in mild asthma.
    Terracciano L; Fiocchi A; Bouygue GR
    N Engl J Med; 2007 Aug; 357(5):506; author reply 506-7. PubMed ID: 17674456
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating the effects of "triple therapy" with inhaled corticosteroids, long-acting beta2-agonists, and leukotriene modifiers in asthma.
    Currie GP; Lee DK; Menzies D; Lipworth BJ
    Chest; 2006 Jul; 130(1):301-2. PubMed ID: 16840420
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.